The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Gene Therapies for Cancer: Strategies, Challenges and Successes
Open accessAbstract
Gene therapy, which involves replacement of a defective gene with a functional, healthy copy of that gene, is a potentially beneficial cancer treatment approach particularly over chemotherapy, which often lacks selectivity and can cause non‐specific toxicity. Despite significant progress pre‐clinically with respect to both enhanced targeting and expression in a tumor‐selective manner several hurdles still prevent success in the clinic, including non‐specific expression, low‐efficiency delivery and biosafety. Various innovative genetic approaches are under development to reconstruct vectors/transgenes to make them safer and more effective. Utilizing cutting‐edge delivery technologies, gene expression can now be targeted in a tissue‐ and organ‐specific manner. With these advances, gene therapy is poised to become amenable for routine cancer therapy with potential to elevate this methodology as a first line therapy for neoplastic diseases. This review discusses recent advances in gene therapy and their impact on a pre‐clinical and clinical level. J. Cell. Physiol. 230: 259–271, 2015. © 2014 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hamed, H. A., Yacoub, A., Park, M. A., Eulitt, P. J., Dash, R., Sarkar, D., Dmitriev, I. P., Lesniak, M. S., Shah, K., Grant, S., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.29 · Cited by 41
Self-citationRetractedMGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“A large number of tumor suppressor genes including p53 (which regulates cell cycle and apoptosis) (Matlashewski et al., 1984; Vogelstein et al., 2000), retinoblastoma gene Rb (which regulates cell cycle and differentiation) (Wiman, 1993), p16INK/CDKN2 (which regulates cell cycle), PTEN (which…”
BackgroundBoussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., et al. (1996) · Science · doi:10.1126/science.274.5286.373 · Cited by 1,760
Rosenberg, S. A., Aebersold, P., Cornetta, K., Kasid, A., Morgan, R. A., Moen, R., Karson, E. M., Lotze, M. T., Yang, J. C., Topalian, S. L., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008303230904 · Cited by 1,318
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Cavazzana-Calvo, M., Payen, E., Negre, O., Wang, G., Hehir, K., Fusil, F., Down, J., Denaro, M., Brady, T., Westerman, K., et al. (2010) · Nature · doi:10.1038/nature09328 · Cited by 1,276
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
Paciotti, G. F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R. E., & Tamarkin, L. (2004) · Drug Delivery · doi:10.1080/10717540490433895 · Cited by 1,185
I nterleukin -10 and R elated C ytokines and R eceptors
Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y., & Fisher, P. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104622 · Cited by 1,094
Self-citationThe "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.
Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., & Abraham, G. N. (1993) · PubMed · Cited by 1,084
Gold nanoparticles as novel agents for cancer therapy
Jain, S., Hirst, D. G., & O'Sullivan, J. M. (2012) · The British Journal of Radiology · doi:10.1259/bjr/59448833 · Cited by 1,059
(2002) · PubMed · Cited by 903
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
Dmitriev, I., Krasnykh, V., Miller, C. R., Wang, M., Kashentseva, E., Mikheeva, G., Belousova, N., & Curiel, D. T. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9706-9713.1998 · Cited by 767
Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.
Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., et al. (1996) · Nature Medicine · doi:10.1038/nm0996-985 · Cited by 703
High‐throughput DNA sequencing – concepts and limitations
Kircher, M., & Kelso, J. (2010) · BioEssays · doi:10.1002/bies.200900181 · Cited by 671
Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
Hacein-Bey-Abina, S., Hauer, J., Lim, A., Picard, C., Wang, G. P., Berry, C. C., Martinache, C., Rieux-Laucat, F., Latour, S., Belohradsky, B. H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000164 · Cited by 639
Progress and prospects: immune responses to viral vectors
Nayak, S., & Herzog, R. W. (2010) · Gene Therapy · doi:10.1038/gt.2009.148 · Cited by 634
Wirth, T., Parker, N., & Ylä-Herttuala, S. (2013) · Gene · doi:10.1016/j.gene.2013.03.137 · Cited by 607
Rodríguez, R., Schuur, E. R., Lim, H. Y., Henderson, G. A., Simons, J. W., & Henderson, D. (1997) · PubMed · Cited by 584
Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications
Abel, E. L., Angel, J. M., Kiguchi, K., & DiGiovanni, J. (2009) · Nature Protocols · doi:10.1038/nprot.2009.120 · Cited by 563
The Myc oncoprotein as a therapeutic target for human cancer
Vita, M., & Henriksson, M. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.015 · Cited by 552
Coyne, C. B., & Bergelson, J. M. (2006) · Cell · doi:10.1016/j.cell.2005.10.035 · Cited by 547
Jiang, H., Lin, J. J., Su, Z.-Z., Goldstein, N. I., & Fisher, P. B. (1995) · PubMed · Cited by 486
Self-citationImaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to α v β 3
Ellegala, D. B., Leong-Poi, H., Carpenter, J. E., Klibanov, A. L., Kaul, S., Shaffrey, M. E., Sklenar, J., & Lindner, J. R. (2003) · Circulation · doi:10.1161/01.cir.0000080326.15367.0c · Cited by 454
Bentley, N. J., Eisen, T., & Goding, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.7996 · Cited by 450
Xiang, Y., Zheng, Q., Jia, B., Huang, G., Xie, C., Pan, J., & Wang, J. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2006.11.012 · Cited by 429
Broderick, J. A., & Zamore, P. D. (2011) · Gene Therapy · doi:10.1038/gt.2011.50 · Cited by 388
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism
Krasnykh, V. N., Mikheeva, G. V., Douglas, J. T., & Curiel, D. T. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6839-6846.1996 · Cited by 387
Dash, P. R., Read, M. L., Barrett, L. B., Wolfert, M. A., & Seymour, L. W. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300843 · Cited by 386
Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity
O'Shea, C. C., Johnson, L., Bagus, B., Choi, S., Nicholas, C., Shen, A., Boyle, L., Pandey, K., Soria, C., Kunich, J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.11.012 · Cited by 372
Microbubble-enhanced ultrasound for vascular gene delivery
Lawrie, A., Brisken, A., Francis, S., Cumberland, D., Crossman, D., & Newman, C. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301339 · Cited by 343
Making sense of cancer genomic data
Chin, L., Hahn, W. C., Getz, G., & Meyerson, M. (2011) · Genes & Development · doi:10.1101/gad.2017311 · Cited by 336
Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules
Vigderman, L., & Zubarev, E. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.05.004 · Cited by 305
Gutless adenovirus: last-generation adenovirus for gene therapy
Alba, R., Bosch, A., & Chillon, M. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302612 · Cited by 303
Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.
Matlashewski, G., Lamb, P., Pim, D., Peacock, J., Crawford, L., & Benchimol, S. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02287.x · Cited by 299
Differentiation therapy of human cancer: basic science and clinical applications
Leszczyniecka, M., Roberts, T., Dent, P., Grant, S., & Fisher, P. B. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00132-2 · Cited by 292
Self-citationHallenbeck, P. L., Chang, Y.-N., Hay, C., Golightly, D., Stewart, D., Lin, J., Phipps, S., & Chiang, Y. L. (1999) · Human Gene Therapy · doi:10.1089/10430349950017725 · Cited by 283
The melanoma differentiation associated gene mda-7 suppresses cancer cell growth.
Jiang, H., Su, Z. Z., Lin, J. J., Goldstein, N. I., Young, C. S., & Fisher, P. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9160 · Cited by 278
Self-citationA brief history of gene therapy
Friedmann, T. (1992) · Nature Genetics · doi:10.1038/ng1092-93 · Cited by 273
Intravascular adenoviral agents in cancer patients: Lessons from clinical trials
Reid, T., Warren, R., & Kirn, D. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700539 · Cited by 258
Kanerva, A., Mikheeva, G., Krasnykh, V. N., Coolidge, C. J., Lam, J. T., Mahasreshti, P. J., Barker, S., Straughn, M. J., Barnes, M. N., Alvarez, R. D., et al. (2002) · PubMed · Cited by 255
Su, Z.-Z., Madireddi, M. T., Lin, J. J., Young, C. S. H., Kitada, S., Reed, J. C., Goldstein, N. I., & Fisher, P. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14400 · Cited by 254
Self-citationVanderplasschen, A., Mathew, E., Hollinshead, M., Sim, R. B., & Smith, G. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7544 · Cited by 249
Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer
MODOK, S., MELLOR, H., & CALLAGHAN, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.01.009 · Cited by 242
Westphal, M., Ylä-Herttuala, S., Martin, J., Warnke, P., Menei, P., Eckland, D., Kinley, J., Kay, R., & Ram, Z. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70274-2 · Cited by 241
Viral vector-based therapeutic cancer vaccines
Larocca, C., & Schlom, J. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e3182325e63 · Cited by 222
p53 Mutations and Survival in Stage I Non-Small-Cell Lung Cancer: Results of a Prospective Study
Ahrendt, S. A., Hu, Y., Buta, M., McDermott, M. P., Benoit, N., Yang, S. C., Wu, L., & Sidransky, D. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.961 · Cited by 222
Gene therapy: designer promoters for tumour targeting
Nettelbeck, D. M., Jérôme, V., & Müller, R. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01950-2 · Cited by 218
DeLong, R., Wanekaya, D. A., Reynolds, M. C., & Schaeffer, A. (2010) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s8984 · Cited by 217
Is mda-7/IL-24 a “Magic Bullet” for Cancer?
Fisher, P. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3127 · Cited by 201
Self-citationTong, A. W., Nemunaitis, J., Su, D., Zhang, Y., Cunningham, C., Senzer, N., Netto, G., Rich, D., Mhashilkar, A., Parker, K., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.021 · Cited by 200
Biodistribution of TNF-α-Coated Gold Nanoparticles in An In Vivo Model System
Goel, R., Shah, N., Visaria, R., Paciotti, G. F., & Bischof, J. C. (2009) · Nanomedicine · doi:10.2217/nnm.09.21 · Cited by 186
Therapeutic ultrasound: Its application in drug delivery
Ng, K., & Liu, Y. (2002) · Medicinal Research Reviews · doi:10.1002/med.10004 · Cited by 178
Ramesh, R., Mhashilkar, A. M., Tanaka, F., Saito, Y., Branch, C. D., Sieger, K., Mumm, J. B., Stewart, A., Boquoi, A., Dumoutier, L., et al. (2003) · PubMed · Cited by 178
Wildner, O., Blaese, R. M., & Morris, J. C. (1999) · PubMed · Cited by 177
Fleming, J. B., Shen, G.-L., Holloway, S. E., Davis, M., & Brekken, R. A. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0206 · Cited by 176 · cited 1×
“(Krens et al., 2010) and disruption of K-ras by antisense RNA leads to apoptosis and tumor growth suppression both in vitro and in vivo in animal models (Fleming et al., 2005).”
BackgroundPolymer gene delivery: overcoming the obstacles
Aied, A., Greiser, U., Pandit, A., & Wang, W. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.06.014 · Cited by 174
A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.
Wirth, T. C., Zender, L., Schulte, B., Mundt, B., Plentz, R. R., Rudolph, K. L., Manns, M. P., Kubicka, S., & Kühnel, F. (2003) · PubMed · Cited by 172
Akada, M., Crnogorac-Jurcevic, T., Lattimore, S., Mahon, P., Lopes, R., Sunamura, M., Matsuno, S., & Lemoine, N. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1785 · Cited by 168
MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine
Sauane, M., Gopalkrishnan, R. V., Sarkar, D., Su, Z.-Z., Lebedeva, I. V., Dent, P., Pestka, S., & Fisher, P. B. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00074-6 · Cited by 155
Self-citationSu, Z.-Z., Lebedeva, I. V., Gopalkrishnan, R. V., Goldstein, N. I., Stein, C., Reed, J. C., Dent, P., & Fisher, P. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171315198 · Cited by 153
Self-citationSu, Z.-Z., Emdad, L., Sauane, M., Lebedeva, I. V., Sarkar, D., Gupta, P., James, C. D., Randolph, A. L., Valerie, K. C., Walter, M. R., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208911 · Cited by 145
Self-citationNettelbeck, D. M., Rivera, Á. A., Balagué, C., Alemany, R., & Curiel, D. T. (2002) · PubMed · Cited by 135
The retinoblastoma gene: role in cell cycle control and cell differentiation
Wiman, K. G. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8393817 · Cited by 133
Telomerase-dependent oncolytic adenovirus for cancer treatment
Huang, T.-G., Savontaus, M., Shinozaki, K., Sauter, B. V., & Woo, S. L. C. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301987 · Cited by 130
Colombo, F., Barzon, L., Franchin, E., Pacenti, M., Pinna, V., Danieli, D., Zanusso, M., & Palù, G. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700851 · Cited by 129
Molecular Biology, Nucleic Acids, and the Future of Medicine
Tatum, E. L. (1966) · Perspectives in biology and medicine · doi:10.1353/pbm.1966.0027 · Cited by 127
Dash, R., Azab, B., Quinn, B. A., Shen, X., Wang, X., Das, S. K., Rahmani, M., Wei, J., Hedvat, M., Dent, P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100769108 · Cited by 126
Self-citationLi, Y., Huang, G., Diakur, J. M., & Wiebe, L. I. (2008) · Current Drug Delivery · doi:10.2174/156720108785915069 · Cited by 125
Anderson, C. R., Rychak, J. J., Backer, M. V., Backer, J. M., Ley, K. F., & Klibanov, A. L. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181efd581 · Cited by 124
Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice
Sarkar, D., Su, Z.-Z., Vozhilla, N., Park, E. S., Gupta, P., & Fisher, P. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506837102 · Cited by 123
Self-citationAutocrine regulation of mda -7/IL-24 mediates cancer-specific apoptosis
Sauane, M., Su, Z.-Z., Gupta, P., Lebedeva, I. V., Dent, P., Sarkar, D., & Fisher, P. B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804089105 · Cited by 120
Self-citationGotoh, A., Ko, S.-C., Shirakawa, T., Cheon, J., Kao, C. H., Miyamoto, T., Gardner, T. A., Ho, L., Cleutjens, C. B. J. M., Trapman, J., et al. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63094-5 · Cited by 120
MDA-7/IL-24: Multifunctional Cancer Killing Cytokine
Menezes, M. E., Bhatia, S., Bhoopathi, P., Das, S. K., Emdad, L., Dasgupta, S., Dent, P., Wang, X., Sarkar, D., & Fisher, P. B. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4471-6458-6_6 · Cited by 118
Self-citationThe Adenovirus Capsid Protein Hexon Contains a Highly Conserved Human CD4 + T-Cell Epitope
Olive, M., Eisenlohr, L. C., Flomenberg, N., Hsu, S. H., & Flomenberg, P. R. (2002) · Human Gene Therapy · doi:10.1089/104303402320138952 · Cited by 117
Pang, S., Taneja, S. S., Dardashti, K., et al. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.11-1417 · Cited by 113
Viral vectors for vaccine applications
Choi, Y., & Chang, J. (2013) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2013.2.2.97 · Cited by 112
Kim, E., Kim, J.-H., Shin, H. Y., Lee, H., Yang, J. M., Kim, J., Sohn, J., Kim, H., & Yun, C. (2003) · Human Gene Therapy · doi:10.1089/104303403769211637 · Cited by 109
mda-7/IL-24: Exploiting Cancer's Achilles' Heel
Lebedeva, I. V., Sauane, M., Gopalkrishnan, R. V., Sarkar, D., Su, Z.-Z., Gupta, P., Nemunaitis, J. J., Cunningham, C. C., Yacoub, A., Dent, P., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.012 · Cited by 106
Self-citationHaviv, Y. S., Blackwell, J. L., Kanerva, A., Nagi, P. A., Krasnykh, V. N., Dmitriev, I. P., Wang, M., Naito, S., Lei, X., Hemminki, A., et al. (2002) · Molecular Therapy · doi:10.1016/s1525-0016(16)44194-8 · Cited by 104
mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity
Dash, R., Bhutia, S. K., Azab, B., Su, Z.-Z., Quinn, B. A., Kegelmen, T. P., Das, S. K., Kim, K., Lee, S., Park, M. A., et al. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.08.004 · Cited by 102
Self-citationNishikawa, T., Ramesh, R., Munshi, A., Chada, S., & Meyn, R. E. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.03.014 · Cited by 101
Shashkova, E. V., Doronin, K., Senac, J. S., & Barry, M. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0488 · Cited by 99
Gene Therapy: The First Approved Gene-Based Medicines, Molecular Mechanisms and Clinical Indications
Räty, J. K., Pikkarainen, J. T., Wirth, T. C., & Ylä‐Herttuala, S. (2008) · Current Molecular Pharmacology · doi:10.2174/1874467210801010013 · Cited by 99
Use of Viruses as Carriers of Added Genetic Information
Rogers, S., & Pfuderer, P. (1968) · Nature · doi:10.1038/219749a0 · Cited by 95
Nanometric gold in cancer nanotechnology: current status and future prospect
Ahmad, M. Z., Akhter, S., Rahman, Z., Akhter, S., Anwar, M., Mallik, N., & Ahmad, F. J. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12017 · Cited by 93
Conde, J., Larguinho, M., Gaspar‐Cordeiro, A., Raposo, L. R., Costa, P. M., Santos, S., Diniz, M., Fernandes, A. R., & Baptista, P. V. (2013) · Nanotoxicology · doi:10.3109/17435390.2013.802821 · Cited by 93
Fisher, P. B., Nemunaitis, J. J., Senzer, N. N., Dent, P., Grant, S., Yacoub, A., Curiel, D. T., Dmitriev, I. P., Mahasreshti, P. J., Pass, A. D., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.5.985 · Cited by 92
Self-citationLarina, I. V., Evers, B. M., Ashitkov, T. V., Bartels, C., Larin, K. V., & Esenaliev, R. O. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400211 · Cited by 91
Philipson, L., & Pettersson, R. F. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05599-1_3 · Cited by 89
TRAIL Gene Therapy: From Preclinical Development to Clinical Application
Griffith, T. S., Stokes, B., Kucaba, T. A., Earel, J. K., VanOosten, R. L., Brincks, E. L., & Norian, L. A. (2009) · Current Gene Therapy · doi:10.2174/156652309787354612 · Cited by 89
Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression
Bhang, H.-E. C., Gabrielson, K. L., Laterra, J., Fisher, P. B., & Pomper, M. G. (2010) · Nature Medicine · doi:10.1038/nm.2269 · Cited by 88
Self-citationIrving, J., Wang, Z., Powell, S., O’Sullivan, C., Mok, M. T. C., Murphy, B., Cardoza, L. M., LEBKOWSKI, J. S., & Majumdar, A. S. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700666 · Cited by 87
Cancer gene therapy targeting cellular apoptosis machinery
Jia, L., Chen, S., & Yang, A. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.06.008 · Cited by 84
Novel Prostate-Specific Promoter Derived from PSA and PSMA Enhancers
Lee, S.-J., Kim, H.-S., Yu, R., Lee, K., Gardner, T. A., Jung, C., Jeng, M., Yeung, F., Liang Cheng, C., & Kao, C. H. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0682 · Cited by 84
Lanson, N. A., Friedlander, P. L., Schwarzenberger, P. O., Kolls, J. K., & Wang, G. (2003) · PubMed · Cited by 82
Restoring apoptosis as a strategy for cancer gene therapy: focus on p53 and mda-7
Lebedeva, I. V., Su, Z.-Z., Sarkar, D., & Fisher, P. B. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00134-7 · Cited by 81
Self-citationKawabe, S., Nishikawa, T., Munshi, A., Roth, J. A., Chada, S., & Meyn, R. E. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0714 · Cited by 80
Greco, A., Benedetto, A. D., Howard, C. M., Kelly, S., Nande, R. P., Dementieva, Y. A., Miranda, M., Brunetti, A., Salvatore, M., Claudio, L., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.252 · Cited by 80
Self-citationUnsuccessful trial of gene replacement in arginase deficiency
Terheggen, H. G., Löwenthal, A., Lavinha, F., Colombo, J. P., & Rogers, S. (1975) · European Journal of Pediatrics · doi:10.1007/bf00464689 · Cited by 79
Su, Z.-Z., Sarkar, D., Emdad, L., Duigou, G. J., Young, C. S. H., Ware, J. L., Randolph, A. L., Valerie, K. C., & Fisher, P. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409141102 · Cited by 78
Self-citationRogers, S., Löwenthal, A., Terheggen, H. G., & Columbo, J. P. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.137.4.1091 · Cited by 77
Effect of Neutralizing Sera on Factor X-Mediated Adenovirus Serotype 5 Gene Transfer
Parker, A. L., Waddington, S. N., Buckley, S. M. K., Custers, J. H. H. V., Havenga, M. J. E., van Rooijen, N., Goudsmit, J., McVey, J. H., Nicklin, S. A., & Baker, A. H. (2008) · Journal of Virology · doi:10.1128/jvi.01878-08 · Cited by 76
Volk, A. L., Rivera, Á. A., Kanerva, A., Bauerschmitz, G. J., Dmitriev, I. P., Nettelbeck, D. M., & Curiel, D. T. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.5.440 · Cited by 72
Adenovirus Strategies for Tissue-Specific Targeting
Beatty, M. S., & Curiel, D. T. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-398342-8.00002-1 · Cited by 71
Dash, R., Richards, J. E., Su, Z.-Z., Bhutia, S. K., Azab, B., Rahmani, M., Dasmahapatra, G. P., Yacoub, A., Dent, P., Dmitriev, I. P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0563 · Cited by 70
Self-citationAdenovirus-mediated cancer gene therapy and virotherapy (Review)
Fukazawa (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000306 · Cited by 70
INGN 201 (Advexin®): adenoviral p53 gene therapy for cancer
Gabrilovich, D. I. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.8.823 · Cited by 68
Telomerase-Specific Oncolytic Virotherapy for Human Cancer with the hTERT Promoter
Fujiwara, T., Urata, Y., & Tanaka, N. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780058835 · Cited by 68
NAYAK, S., CAO, O., HOFFMAN, B. E., COOPER, M., ZHOU, S., ATKINSON, M. A., & HERZOG, R. W. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03548.x · Cited by 66
Howard, C. M., Forsberg, F., Minimo, C., Liu, J., Merton, D. A., & Claudio, P. P. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20736 · Cited by 65
Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond
Kaufmann, J. K., & Nettelbeck, D. M. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.008 · Cited by 65
Li, X., Zhang, Y.-P., Kim, H.-S., Bae, K.-H., Stantz, K. M., Lee, S.-J., Jung, C., Jimènez, J. A., Gardner, T. A., Jeng, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3666 · Cited by 64
Farma, J. M., Puhlmann, M., Soriano, P. A., Cox, D., Paciotti, G. F., Tamarkin, L., & Alexander, H. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22270 · Cited by 62
Adenovirus-mediated cancer gene therapy and virotherapy (Review).
Fukazawa, T., Matsuoka, J., Yamatsuji, T., et al. (2010) · PubMed · Cited by 59
Sarkar, D., Su, Z.-Z., Vozhilla, N., Park, E. S., Randolph, A. L., Valerie, K. C., & Fisher, P. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1261 · Cited by 56
Self-citationZhang, Z., Krimmel‐Morrison, J. D., Zhang, Z., Hu, Z., & Seth, P. K. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.003 · Cited by 54
MDA-7/IL-24 as a cancer therapeutic: from bench to bedside
Dent, P., Yacoub, A., Hamed, H. A., et al. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833cfbe1 · Cited by 54
Melanoma differentiation associated gene-7 (mda-7)/IL-24: a ‘magic bullet’ for cancer therapy?
Sarkar, D., Lebedeva, I. V., Gupta, P., Emdad, L., Sauane, M., Dent, P., Curiel, D. T., & Fisher, P. B. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.5.577 · Cited by 54
Self-citationFournillier, A., Frelin, L., Jacquier, E., Ahlén, G., Braß, A., Gerossier, E., Holmström, F., Broderick, K. E., Sardesai, N. Y., Bonnefoy, J., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit267 · Cited by 53
Development of new RNAi therapeutics.
Liu, G., Wong‐Staal, F., & Li, Q.-X. (2007) · PubMed · doi:10.14670/hh-22.211 · Cited by 52
The Biotech Death of Jesse Gelsinger
Stolberg, S. G. (1999) · DigitalGeorgetown (Georgetown University Library) · Cited by 50
Zheng, M., Bocangel, D., Ramesh, R., Ekmekçioglu, S., Poindexter, N. J., Grimm, E. A., & Chada, S. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0516 · Cited by 49
Azab, B., Dash, R., Das, S. K., Bhutia, S. K., Shen, X., Quinn, B. A., Sarkar, S., Wang, X., Hedvat, M., Dmitriev, I. P., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22947 · Cited by 48
Self-citationTherapeutic modulation of k-ras signaling in colorectal cancer
Krens, L. L., Baas, J. M., Gelderblom, H. A. J., & Guchelaar, H. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.05.012 · Cited by 46
McKie, E. A., Graham, D. I., & Brown, S. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300621 · Cited by 42
Lebedeva, I. V., Su, Z.-Z., Vozhilla, N., Chatman, L., Sarkar, D., Dent, P., Athar, M., & Fisher, P. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0072 · Cited by 40
Self-citationGene therapy for high-grade glioma: Current approaches and future directions
Natsume, A., & Yoshida, J. (2008) · Cell Adhesion & Migration · doi:10.4161/cam.2.3.6278 · Cited by 38
Xie, X., Mathias, J. R., Smith, M.-A., Walker, S. L., Teng, Y., Distel, M., Köster, R. W., Sirotkin, H. I., Saxena, M. T., & Mumm, J. S. (2012) · BMC Biology · doi:10.1186/1741-7007-10-93 · Cited by 37
Enhanced Anti-Tumor Effects with Microencapsulated c- myc Antisense Oligonucleotide
Putney, S. D., Brown, J. N., Cucco, C., Lee, R., Skórski, T., Leonetti, C., Geiser, T., Calabretta, B., Zupi, G., & Zon, G. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.451 · Cited by 36
Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors
Chan, J. K. Y., & Lam, P. Y. P. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2013.59 · Cited by 34
A First-Generation Multi-Functional Cytokine for Simultaneous Optical Tracking and Tumor Therapy
Hingtgen, S., Kasmieh, R., Elbayly, E., Nesterenko, I., Figueiredo, J., Dash, R., Sarkar, D., Hall, D. R., Kozakov, D., Vajda, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040234 · Cited by 33
Self-citationRapamycin control of transgene expression from a single AAV vector in mouse salivary glands
Wang, J., Voutetakis, A., Papa, M., Rivera, V. M., Clackson, T., Lodde, B. M., Mineshiba, F., & Baum, B. J. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302647 · Cited by 27
Hoffmann, D., & Wildner, O. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0374 · Cited by 25
Tumor Suppressor Gene-Based Nanotherapy: From Test Tube to the Clinic
Shanker, M., Jin, J., Branch, C. D., Miyamoto, S., Grimm, E. A., Roth, J. A., & Ramesh, R. (2011) · Journal of Drug Delivery · doi:10.1155/2011/465845 · Cited by 24
Lai, T. C., Kataoka, K., & Kwon, G. S. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.09.026 · Cited by 24
Nishikawa, T., Munshi, A., Story, M. D., Ismail, S. M., Stevens, C., Chada, S., & Meyn, R. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207917 · Cited by 24
Gu, J., Chen, X., Xin, H., Fang, X., & Sha, X. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.12.029 · Cited by 21
Enhancing Complement Control on Endothelial Barrier Reduces Renal Post-Ischemia Dysfunction
Pushpakumar, S. B., Perez‐Abadia, G., Soni, C., Wan, R., Todnem, N. D., Patibandla, P. K., Fensterer, T., Zhang, Q., Barker, J. H., & Maldonado, C. J. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.06.010 · Cited by 17
Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer
Fujiwara, T., Shirakawa, Y., & Kagawa, S. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.200 · Cited by 17
Gandhi, J., Cashman, S. M., & Kumar-Singh, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021621 · Cited by 16
Sokhi, U. K., Bacolod, M. D., Dasgupta, S., Emdad, L., Das, S. K., Dumur, C. I., Miles, M. F., Sarkar, D., & Fisher, P. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076284 · Cited by 13
Self-citationPal, I., Sarkar, S., Rajput, S., Dey, K. K., Chakraborty, S., Dash, R., Das, S. K., Sarkar, D., Barile, E., De, S. K., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.227 · Cited by 13
Self-citation(1999) · PubMed
Cited by
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998
Polyphenol‐Containing Nanoparticles: Synthesis, Properties, and Therapeutic Delivery
Guo, Y., Sun, Q., Wu, F., Dai, Y., & Chen, X. (2021) · Advanced Materials · doi:10.1002/adma.202007356 · Cited by 650
DNA Vaccines—How Far From Clinical Use?
Hobernik, D., & Bros, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113605 · Cited by 457
Tombácz, I., Laczkó, D., Shahnawaz, H., Muramatsu, H., Natesan, A., Yadegari, A., Papp, T. E., Alameh, M.-G., Shuvaev, V., Mui, B. L., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.06.004 · Cited by 296
Metadata
- Authors
- Das, S. K., Menezes, M. E., Bhatia, S., Wang, X., Emdad, L., Sarkar, D., & Fisher, P. B.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2014-10-28
- Volume
- 230
- Issue
- 2
- Pages
- 259-271
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W1591560031
- Cited by
- 284
- References
- 149
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.